The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 05, 2016
Filed:
Jun. 27, 2014
Applicants:
Abbott Laboratories, Abbott Park, IL (US);
Abbvie Deutschland Gmbh & CO KG, Wiesbaden, DE;
Inventors:
Frauke Pohlki, Wiesbaden, DE;
Udo Lange, Wiesbaden, DE;
Wilhelm Amberg, Wiesbaden, DE;
Michael Ochse, Wiesbaden, DE;
Berthold Behl, Wiesbaden, DE;
Charles W. Hutchins, Green Oaks, IL (US);
Assignees:
AbbVie Inc., North Chicago, IL (US);
AbbVie Deutschland GmbH & Co. KG, Wiesbaden, DE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/135 (2006.01); C07C 211/27 (2006.01); C07C 311/14 (2006.01); C07C 311/10 (2006.01); C07D 205/04 (2006.01); C07D 231/18 (2006.01); C07D 403/12 (2006.01); C07D 233/84 (2006.01);
U.S. Cl.
CPC ...
C07C 311/14 (2013.01); C07C 311/10 (2013.01); C07D 205/04 (2013.01); C07D 231/18 (2013.01); C07D 233/84 (2013.01); C07D 403/12 (2013.01); C07C 2101/02 (2013.01); C07C 2102/08 (2013.01);
Abstract
The present invention relates to aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminoindane derivatives, and the use of such aminoindane derivatives for therapeutic purposes. The aminoindane derivatives are GlyT1 inhibitors.